Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12621001076864
Ethics application status
Approved
Date submitted
29/06/2021
Date registered
16/08/2021
Date last updated
27/10/2023
Date data sharing statement initially provided
16/08/2021
Type of registration
Prospectively registered
Titles & IDs
Public title
Assessing the intake of nutritional beverages in hospitalised older adults
Query!
Scientific title
A randomised single-blinded intervention study investigating the intake of nutritional beverages in hospitalised older adults
Query!
Secondary ID [1]
304616
0
None
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Malnutrition
322534
0
Query!
At risk of malnutrition
322939
0
Query!
Condition category
Condition code
Diet and Nutrition
320163
320163
0
0
Query!
Other diet and nutrition disorders
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
This study aims to assess the intake of nutritional beverages in hospitalised adults undergoing lower GI surgery.
WHAT:
Participants identified undergoing lower GI surgery will be invited to participate in the stufy. They will be offere the intervention beverage or follow standard treatment. The intervention beverage has a proprietary formulation which has been formulated to increase palatability and gastric comfort.
WHO PROVIDED:
The intervention will be conducted by research dieticians/research nurses/research assistants and will be overseen by a University researcher.
HOW & WHERE:
The intervention will take place in a hospital, and patients will be recruited form the lower GI surgical wards. The research dietician will collect the data whilst the participants are in hospital.
WHEN & HOW MUCH:
Participants will be given two serves per day. The beverages will be supplied to the participants for up to 30 days, or until they request to stop taking them, or until they are no longer at risk of malnutrition. The amount of beverage consumed per occasion will be determined, and documented, by the research dietician/research nurse.
Query!
Intervention code [1]
320976
0
Treatment: Other
Query!
Comparator / control treatment
The control group will be given a standard care, which follows the enhanced recovery after surgery protocol. This change was made prior to recruitment commencing.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
336415
0
Muscle mass using US
Query!
Assessment method [1]
336415
0
Query!
Timepoint [1]
336415
0
Query!
Primary outcome [2]
336416
0
Muscle mass using US
Query!
Assessment method [2]
336416
0
Query!
Timepoint [2]
336416
0
Muscle mass will be assessed at baseline, 1 day post-operatively, and at the end of the intervention
Query!
Secondary outcome [1]
428255
0
Grip strength using a dynamometer
Query!
Assessment method [1]
428255
0
Query!
Timepoint [1]
428255
0
Query!
Secondary outcome [2]
428256
0
Grip strength using a dynamometer
Query!
Assessment method [2]
428256
0
Query!
Timepoint [2]
428256
0
Grip strength will be assesed at baseline, 1 day post-operatively and at the end of the intervention
Query!
Secondary outcome [3]
428257
0
Compliance wil be measured through measuring the amount of beverage pre-and port-consumption. This will be done either by the participant or by one of the research team.
Query!
Assessment method [3]
428257
0
Query!
Timepoint [3]
428257
0
Grip strength will be assesed at baseline, 1 day post-operatively and at the end of the intervention
Query!
Secondary outcome [4]
428258
0
Compliance wil be measured through measuring the amount of beverage pre-and port-consumption. This will be done either by the participant or by one of the research team.
Query!
Assessment method [4]
428258
0
Query!
Timepoint [4]
428258
0
This will be done daily throughout the intervention
Query!
Secondary outcome [5]
428259
0
Nutritional status through 24-hour diet recall
Query!
Assessment method [5]
428259
0
Query!
Timepoint [5]
428259
0
This will be done daily throughout the intervention
Query!
Secondary outcome [6]
428260
0
Nutritional status through 24-hour diet recall
Query!
Assessment method [6]
428260
0
Query!
Timepoint [6]
428260
0
Nutrtional status will be measured at baseline and weekly througout the intervention and at the end of the intervention
Query!
Eligibility
Key inclusion criteria
Hospitalised
Undergoing lower GI surgery
Able to provide informed consent
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Cannot provide informed consent
Renal status would contraindicate the consumption of the supplement
Have a planned discharge within 48 hours of starting the supplementation
Have a terminal illness requiring palliative care
Have a dairy of soy allergy
Require Halal or Kosher diets
Require nasogastric or parental feeding
Are taking dietary supplements which could influence the outcome of the study
Have a clinical condition that, in the investigator’s judgement, could interfere with the intestinal barrier function
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Central randomisation by computer
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Computer generated randomisation
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people assessing the outcomes
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Sample size calculations are based on previous research findings investigating compliance levels with similar nutrition supplements in a similar population group.
Continuous baseline data will be presented as mean and standard deviation (normally distributed) or median and inter-quartile range (non-normal distribution)
Categorical data will be grouped appropriately and presented as count and percentage.
Main analysis will focus on change from baseline to end of intervention. Analysis of Covariance model will include a minimum of treatment group and treatment duration but may include additional confounding factors as required.
Secondary analyses for parameters measured on multiple occasions will include repeated measure Analysis of Variance.
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
13/11/2023
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
27/09/2024
Query!
Actual
Query!
Date of last data collection
Anticipated
15/11/2024
Query!
Actual
Query!
Sample size
Target
60
Query!
Accrual to date
Query!
Final
Query!
Recruitment outside Australia
Country [1]
23921
0
New Zealand
Query!
State/province [1]
23921
0
Auckland
Query!
Funding & Sponsors
Funding source category [1]
308976
0
Commercial sector/Industry
Query!
Name [1]
308976
0
Fonterra Research and Development Centre
Query!
Address [1]
308976
0
Fonterra Co-operative Group Limited
Private Bag 11029
Palmerston North 4442
Query!
Country [1]
308976
0
New Zealand
Query!
Primary sponsor type
Commercial sector/Industry
Query!
Name
Fonterra Research and Development Centre
Query!
Address
Fonterra Co-operative Group Limited
Private Bag 11029
Palmerston North 4442
Query!
Country
New Zealand
Query!
Secondary sponsor category [1]
309910
0
None
Query!
Name [1]
309910
0
Query!
Address [1]
309910
0
Query!
Country [1]
309910
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
308868
0
Health and Disability Ethics Committee
Query!
Ethics committee address [1]
308868
0
Ministry of Health Health and Disability Ethics Committees PO Box 5013 Wellington 6140
Query!
Ethics committee country [1]
308868
0
New Zealand
Query!
Date submitted for ethics approval [1]
308868
0
08/07/2021
Query!
Approval date [1]
308868
0
18/09/2023
Query!
Ethics approval number [1]
308868
0
Query!
Summary
Brief summary
The study aims to determine whether a proprietary nutritional supplement is more effective than a standard supplement in meeting the nutritional needs of elderly hospitalised patients. The hypothesis states that greater improvements in compliance, and subsequently nutrition status, will be seen in those participants who are given the proprietary supplement.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
112162
0
Dr Andrea Braakhuis
Query!
Address
112162
0
Academic Director
Nutrition and Dietetics
Faculty of Medical and Health Sciences
University of Auckland
85 Park Road
Grafton
Auckland 1023
Query!
Country
112162
0
New Zealand
Query!
Phone
112162
0
+64 9 923 6251
Query!
Fax
112162
0
Query!
Email
112162
0
[email protected]
Query!
Contact person for public queries
Name
112163
0
Andrea Braakhuis
Query!
Address
112163
0
Academic Director
Nutrition and Dietetics
Faculty of Medical and Health Sciences
University of Auckland
85 Park Road
Grafton
Auckland 1023
Query!
Country
112163
0
New Zealand
Query!
Phone
112163
0
+64 9 923 6251
Query!
Fax
112163
0
Query!
Email
112163
0
[email protected]
Query!
Contact person for scientific queries
Name
112164
0
Karen Munday
Query!
Address
112164
0
Fonterra Co-operative Group Limited
Private Bag 11029
Palmerston North 4442
Query!
Country
112164
0
New Zealand
Query!
Phone
112164
0
+64 6 350 6567
Query!
Fax
112164
0
Query!
Email
112164
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Release of clinical trial data may compromise future patents and other intellectual property assets
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF